NfL as a Predictor of GdE Lesions in Patients With Relapsing Multiple Sclerosis Treated With Ozanimod in the Phase 2 RADIANCE TrialSarah Harris,Patrick Vermersch,Xavier Montalban,Hans-Peter Hartung,Ludwig Kappos,Harry Southworth,James K. Sheffield,Diego Silva,Jeffrey A. CohenMULTIPLE SCLEROSIS JOURNAL(2023)引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要